Mood Disorder

Patients with mood or anxiety disorders had significant rates of PTSD, depressive and anxiety symptoms that often persisted beyond 3 months following lockdown for the COVID-19 pandemic, according to study results.

The majority of patients with systemic lupus erythematosus experience persistent depression despite disease activity changes and use of medications for mood disorders, pain and lupus, according to data published in Arthritis Care & Research.

Daily use of omega-3 in older adults at risk for depression correlated with a slight increase in depressive symptoms while having no effect on mood, according to a randomized clinical trial published in JAMA.

Results of a 5-year study in Japan suggest pulmonary embolism may be a major cause of sudden cardiac arrest among patients with psychiatric disorders.

Referrals from primary care providers to Pediatric Mental Health Care Access programs rose and involved more complex mental health concerns during the COVID-19 pandemic, according to study results.

Patients with major psychiatric disorders appeared to have higher rates of medical comorbidities linked to worse COVID-19 outcomes, according to results of a cross-sectional study published in JAMA Network Open.

The COVID-19 pandemic may have reduced overall mood and physical activity among study participants and increased their levels of self-reported stress, a speaker reported.

The FDA has granted 510(k) clearance to neuroscience research and mental health treatment company Magstim for Horizon 3.0, its transcranial magnetic stimulation platform.

Vulnerable subgroups of veterans had increased risk for cannabis use disorder and nonmedical use, according to results of a survey study published in American Journal of Psychiatry.

People with preexisting mood disorders had increased risk for COVID-19 hospitalization and death, according to results of a systematic review and meta-analysis published in JAMA Psychiatry.